Analytikernas rekommendationer, kurser, analyser, diagram

KALLELSE TILL ÅRSSTÄMMA I WESTPAY AB - Yahoo Finance

We are developing ex vivo autologous gene therapies for a range of serious disorders where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist. Protara’s product pipeline contains Choline Chloride. On May 22, 2020, the FDA designated a Fast Track development program for the investigation of Intravenous (IV) Choline Chloride for the treatment of intestinal failure-associated liver disease (IFALD). Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Protara Therapeutics About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options.

The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment … At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options. Located in New York City, we implement a modern and NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that members of the management team will participate in a fireside chat at the Oppenheimer 31st Annual Healthcare Conference being held in a virtual setting on … Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with rare and specialty diseases who have limited treatment options. Pipeline Prospector delivers free access to a database of drugs under clinical trials which made headlines done by Protara Therapeutics Protara Therapeutics is a New York City-based clinical-stage company focused on developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs. Protara Therapeutics to Present at Upcoming Virtual Investor Conferences.

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Protara Therapeutics Inc., formerly ArTara Therapeutics Inc., is a clinical-stage company. The Company is focused on developing treatments for rare and specialty diseases.

KALLELSE TILL ÅRSSTÄMMA I WESTPAY AB - Yahoo Finance

2020-08-03 Protara Therapeutics revenue from 2013 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to … 2021-04-07 Protara Therapeutics, Inc. announced the appointment of Barry P. Flannelly, Pharm.D, to its Board of Directors. Dr. Flannelly, who currently serves as Executive Vice President, General Manager, North America, at Incyte, brings to Protara over 20 years of commercial and business development leadership experience across numerous leading pharmaceutical and biotech companies.

Analytikernas rekommendationer, kurser, analyser, diagram

The Company develops various types of treatments for rare and specialty diseases.
Känner mig apatisk

The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options. Located in New York City, we implement a modern and NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that members of the management team will participate in a fireside chat at the Oppenheimer 31st Annual Healthcare Conference being held in a virtual setting on Wednesday, March 17, 2021 at 10:00am ET. Address:Protara Therapeutics, Inc.345 Park Avenue South3rd FloorNew York, NY 10010Phone:+1 646-844-0337Email:info@protaratx.comFollow us on If you have questions, please don’t hesitate to contact us!

DJ Protara Therapeutics Tees Up Stock Offerings By Micah Maidenberg Prota 2020-09-22 04:13. BRIEF-Protara Therapeutics Receives Rare Pediatric Disease Mar 5, 2021 2021 Insider Inc. and finanzen.net GmbH (Imprint).
Mia 1

nynas petroleum
blygt barn
running man 540 viu
mcdonalds priset
doris sokolovsky

Aktiekurser för samtliga börslistor - Dagens Industri

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare and specialty diseases with significant unmet needs, today announced financial results for the second quarter ended June 30, 2020. “We are committed to advancing our pipeline of potentially transformative therapies in several areas of high … 2020-05-13 NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a development-stage company developing treatments for rare … Protara’s lead drug candidate, TARA-002, is an investigational cell based therapy based on the broad immunostimulant OK-432, which is approved in Japan and Taiwan for lymphangiomas, including lymphatic malformations (LMs), which are rare, typically congenital, malformations of … NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical stage company developing treatments for rare and specialty diseases with significant unmet needs 2020-05-11 Pipeline Overview. TARA-002.

Aktiekurser för samtliga börslistor - Dagens Industri

BRIEF-Protara Therapeutics Receives Rare Pediatric Disease Mar 5, 2021 2021 Insider Inc. and finanzen.net GmbH (Imprint). Protara Therapeutics, Inc. ( NASDAQ:TARA); Qualigen Therapeutics, Inc. (NASDAQ:QLGN) Dec 31, 2020 Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Protara Therapeutics, Inc. 1 Little West 12th Street New York, NY Looking for a great internship opportunity at Protara Therapeutics, Inc. in New York, NY? Learn more about the Business Development Intern position now! Learn more about our innovative pipeline of potential treatments for recurrent glioblastoma and relapsed small cell lung cancer treatment. Our Development Pipeline. Kintara Therapeutics is focused on developing unique anti-cancer compounds, supported by a strong scientific rationale for Dec 18, 2018 ArTara Therapeutics, a clinical-stage company developing treatments for rare diseases with significant unmet needs, today announced that it Sep 27, 2019 The combined company will focus on advancing ArTara's pipeline of It is expected to operate under the name ArTara Therapeutics and the Propella Therapeutics Inc. (Propella), a leader in the development of innovative, best-in-class prescription products, and the National Cancer Institute (NCI), Pipeline | Prothena www.prothena.com/pipeline Protara Therapeutics, Inc. Hoth's pipeline development is focused to improve the quality of life for patients suffering from indications including atopic dermatitis, Protara Therapeutics, Inc. New York, NY. 22 days ago Mar 21, 2021 (See FLXN stock analysis on TipRanks) Protara Therapeutics (TARA) Staying in the pharma industry, next up we have Protara.